The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kim Robert Young since 2024.
This trader's CIK number is 1971608.
At the time of last reporting, Kim Robert Young was the Chief Medical Officer of 4d Molecular Therapeutics, Inc.. (stock ticker symbol FDMT).
Also see all insider trading activities at 4d Molecular Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | FDMT | 0 | $0 | 24,552 | $737,787 | 24,000 | $339,840 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-05 | FDMT | Sale | 24,552 | 30.05 | 737,787 |
| 2024-02-05 | FDMT | Option Ex | 24,000 | 14.16 | 339,840 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kim Robert Young (Chief Medical Officer of 4d Molecular Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.